BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 10601613)

  • 1. Pharmacokinetics of intrapleural cisplatin for the treatment of malignant pleural effusions.
    Monjanel-Mouterde S; Frenay C; Catalin J; Boutin C; Durand A; Astoul P
    Oncol Rep; 2000; 7(1):171-5. PubMed ID: 10601613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrapleural cisplatin and mitomycin for malignant mesothelioma following pleurectomy: pharmacokinetic studies.
    Rusch VW; Niedzwiecki D; Tao Y; Menendez-Botet C; Dnistrian A; Kelsen D; Saltz L; Markman M
    J Clin Oncol; 1992 Jun; 10(6):1001-6. PubMed ID: 1588364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High doses of intrapleural cisplatin in a case of malignant pleural mesothelioma. Clinical observations and pharmacokinetic analyses.
    Lerza R; Esposito M; Vannozzi M; Bottino GB; Bogliolo G; Pannacciulli I
    Cancer; 1994 Jan; 73(1):79-84. PubMed ID: 8275441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I clinical and pharmacological study of liposome-entrapped NDDP administered intrapleurally in patients with malignant pleural effusions.
    Perez-Soler R; Shin DM; Siddik ZH; Murphy WK; Huber M; Lee SJ; Khokhar AR; Hong WK
    Clin Cancer Res; 1997 Mar; 3(3):373-9. PubMed ID: 9815694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrapleural administration of cisplatin and etoposide to treat malignant pleural effusions in patients with non-small cell lung cancer.
    Tohda Y; Iwanaga T; Takada M; Yana T; Kawahara M; Negoro S; Okishio K; Kudoh S; Fukuoka M; Furuse K
    Chemotherapy; 1999; 45(3):197-204. PubMed ID: 10224342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic evaluation of intrapleural perfusion with hyperthermic chemotherapy using cisplatin in patients with malignant pleural effusion.
    Sakaguchi H; Ishida H; Nitanda H; Yamazaki N; Kaneko K; Kobayashi K
    Lung Cancer; 2017 Feb; 104():70-74. PubMed ID: 28213004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional pharmacokinetic selectivity of intrapleural cisplatin.
    Bogliolo GV; Lerza R; Bottino GB; Mencoboni MP; Pannacciulli IM; Vannozzi M; Fulco RA; Merlo F; Esposito M
    Eur J Cancer; 1991; 27(7):839-42. PubMed ID: 1834113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carboplatin and cisplatin pharmacokinetics after intrapleural combination treatment in patients with malignant pleural effusion.
    Lerza R; Vannozzi MO; Tolino G; Viale M; Bottino GB; Bogliolo G; Cerruti A; Castello G; Mencoboni M; Reggiardo G; Pannacciulli I; Esposito M
    Ann Oncol; 1997 Apr; 8(4):385-91. PubMed ID: 9209670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of intrapleural recombinant interleukin-2 in immunotherapy for malignant pleural effusion.
    Astoul P; Bertault-Peres P; Durand A; Catalin J; Vignal F; Boutin C
    Cancer; 1994 Jan; 73(2):308-13. PubMed ID: 8293393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies on an appropriate intra thoracic administration of cisplatin and sodium thiosulfate in malignant pleural effusion].
    Kitajima K; Fukuoka M; Kusunoki Y; Negoro S; Takada M; Matsui K; Sakai N; Ryu S; Takifuji N; Masuda N
    Gan To Kagaku Ryoho; 1988 Dec; 15(12):3253-9. PubMed ID: 3196043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Intrapleural administration of CDDP against malignant pleural effusions in breast cancer].
    Kikuchi K; Tsuyuki A; Fujishiro Y; Utsumi T; Fujisaki M; Kurihara E; Uematsu M
    Gan To Kagaku Ryoho; 1990 Sep; 17(9):1905-8. PubMed ID: 2393307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrapleural cisplatin and cytarabine in the management of malignant pleural effusions: a Lung Cancer Study Group trial.
    Rusch VW; Figlin R; Godwin D; Piantadosi S
    J Clin Oncol; 1991 Feb; 9(2):313-9. PubMed ID: 1988578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local and systemic exposure of cisplatin during hyperthermic intrathoracic chemotherapy perfusion after pleurectomy and decortication for treatment of pleural malignancies.
    Ried M; Potzger T; Braune N; Diez C; Neu R; Sziklavari Z; Schalke B; Hofmann HS
    J Surg Oncol; 2013 Jun; 107(7):735-40. PubMed ID: 23386426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Palliative and therapeutic activity of IL-2 immunotherapy in unresectable malignant pleural mesothelioma with pleural effusion: Results of a phase II study on 31 consecutive patients.
    Castagneto B; Zai S; Mutti L; Lazzaro A; Ridolfi R; Piccolini E; Ardizzoni A; Fumagalli L; Valsuani G; Botta M
    Lung Cancer; 2001; 31(2-3):303-10. PubMed ID: 11165411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of hypotonic cisplatin chemotherapy administered into the peritoneal and the pleural cavities in experimental model.
    Katano K; Tsujitani S; Oka S; Saito H; Gomyo Y; Kondo A; Ikeguchi M; Maeta M; Kaibara N
    Anticancer Res; 2000; 20(3A):1603-7. PubMed ID: 10928078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of intrapleural OK-432 and cisplatin for malignant pleural effusion in lung cancer patients].
    Shimizu T; Takahashi N; Terakado M; Sato M; Sugane T; Kisohara A; Akusawa H; Tsujino I; Horie T
    Gan To Kagaku Ryoho; 2005 Aug; 32(8):1139-43. PubMed ID: 16121916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I trial of intrapleural docetaxel administered through an implantable catheter in subjects with a malignant pleural effusion.
    Jones DR; Taylor MD; Petroni GR; Shu J; Burks SG; Daniel TM; Gillenwater HH
    J Thorac Oncol; 2010 Jan; 5(1):75-81. PubMed ID: 19884858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cisplatin and cytarabine administered intrapleurally as treatment of malignant pleural effusions.
    Markman M; Cleary S; King ME; Howell SB
    Med Pediatr Oncol; 1985; 13(4):191-3. PubMed ID: 4040205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase II trial of pleurectomy/decortication followed by intrapleural and systemic chemotherapy for malignant pleural mesothelioma.
    Rusch V; Saltz L; Venkatraman E; Ginsberg R; McCormack P; Burt M; Markman M; Kelsen D
    J Clin Oncol; 1994 Jun; 12(6):1156-63. PubMed ID: 8201377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of remission in diffuse pleural mesothelioma induced by anticancer chemotherapy with cisplatin and adriamycin].
    Kinoshita S; Yamashita T; Yagi M; Bando H; Tsubura E; Sano T
    Gan To Kagaku Ryoho; 1985 Sep; 12(9):1872-6. PubMed ID: 4041164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.